Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a rare variant of breast cancer (BC) known to be aggressive and refractory. TNBC lacks effective early diagnostic and therapeutic options leading to poorer outcomes. The genomic landscape and alterations leading to BC and TNBC are vast and unclear. Single nucl...

Full description

Bibliographic Details
Main Authors: Vigneshwaran G., Qurratulain Annie Hasan, Rahul Kumar, Avinash Eranki
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.1071352/full
_version_ 1811178092637454336
author Vigneshwaran G.
Qurratulain Annie Hasan
Rahul Kumar
Avinash Eranki
author_facet Vigneshwaran G.
Qurratulain Annie Hasan
Rahul Kumar
Avinash Eranki
author_sort Vigneshwaran G.
collection DOAJ
description Triple-negative breast cancer (TNBC) is a rare variant of breast cancer (BC) known to be aggressive and refractory. TNBC lacks effective early diagnostic and therapeutic options leading to poorer outcomes. The genomic landscape and alterations leading to BC and TNBC are vast and unclear. Single nucleotide polymorphisms (SNPs) are a widespread form of genetic alterations with a multi-faceted impact on multiple diseases, including BC and TNBC. In this study, we attempted to construct a framework that could identify genes associated with TNBC and screen the SNPs reported in these genes using a set of computational predictors. This framework helped identify BRCA1, BRCA2, EGFR, PIK3CA, PTEN, and TP53 as recurrent genes associated with TNBC. We found 2%–29% of reported SNPs across genes to be typed pathogenic by all the predictors in the framework. We demonstrate that our framework prediction on BC samples identifies 99% of alterations as pathogenic by at least one predictor and 32% as pathogenic by all the predictors. Our framework could be an initial step in developing an early diagnosis of TNBC and potentially help improve the understanding of therapeutic resistance and sensitivity.
first_indexed 2024-04-11T06:13:39Z
format Article
id doaj.art-f1bf314b5a1e4404b6d670e7c4365516
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-11T06:13:39Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-f1bf314b5a1e4404b6d670e7c43655162022-12-22T04:41:09ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-12-011310.3389/fgene.2022.10713521071352Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancerVigneshwaran G.0Qurratulain Annie Hasan1Rahul Kumar2Avinash Eranki3Department of Biomedical Engineering, Indian Institute of Technology Hyderabad, Hyderabad, Telangana, IndiaDepartment of Genetics and Molecular Medicine, Kamineni Hospitals, Hyderabad, Telangana, IndiaDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Hyderabad, Telangana, IndiaDepartment of Biomedical Engineering, Indian Institute of Technology Hyderabad, Hyderabad, Telangana, IndiaTriple-negative breast cancer (TNBC) is a rare variant of breast cancer (BC) known to be aggressive and refractory. TNBC lacks effective early diagnostic and therapeutic options leading to poorer outcomes. The genomic landscape and alterations leading to BC and TNBC are vast and unclear. Single nucleotide polymorphisms (SNPs) are a widespread form of genetic alterations with a multi-faceted impact on multiple diseases, including BC and TNBC. In this study, we attempted to construct a framework that could identify genes associated with TNBC and screen the SNPs reported in these genes using a set of computational predictors. This framework helped identify BRCA1, BRCA2, EGFR, PIK3CA, PTEN, and TP53 as recurrent genes associated with TNBC. We found 2%–29% of reported SNPs across genes to be typed pathogenic by all the predictors in the framework. We demonstrate that our framework prediction on BC samples identifies 99% of alterations as pathogenic by at least one predictor and 32% as pathogenic by all the predictors. Our framework could be an initial step in developing an early diagnosis of TNBC and potentially help improve the understanding of therapeutic resistance and sensitivity.https://www.frontiersin.org/articles/10.3389/fgene.2022.1071352/fulloncogenomicscomputational biologyinsilicosingle nucleotide polymorphismtriple negative breast cancer
spellingShingle Vigneshwaran G.
Qurratulain Annie Hasan
Rahul Kumar
Avinash Eranki
Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer
Frontiers in Genetics
oncogenomics
computational biology
insilico
single nucleotide polymorphism
triple negative breast cancer
title Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer
title_full Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer
title_fullStr Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer
title_full_unstemmed Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer
title_short Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer
title_sort analysis of single nucleotide polymorphisms in genes associated with triple negative breast cancer
topic oncogenomics
computational biology
insilico
single nucleotide polymorphism
triple negative breast cancer
url https://www.frontiersin.org/articles/10.3389/fgene.2022.1071352/full
work_keys_str_mv AT vigneshwarang analysisofsinglenucleotidepolymorphismsingenesassociatedwithtriplenegativebreastcancer
AT qurratulainanniehasan analysisofsinglenucleotidepolymorphismsingenesassociatedwithtriplenegativebreastcancer
AT rahulkumar analysisofsinglenucleotidepolymorphismsingenesassociatedwithtriplenegativebreastcancer
AT avinasheranki analysisofsinglenucleotidepolymorphismsingenesassociatedwithtriplenegativebreastcancer